Korro Bio (KRRO) Equity Ratio (2019 - 2025)
Korro Bio (KRRO) has disclosed Equity Ratio for 6 consecutive years, with 0.61 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Equity Ratio fell 16.89% year-over-year to 0.61, compared with a TTM value of 0.61 through Sep 2025, down 16.89%, and an annual FY2024 reading of 0.71, down 7.5% over the prior year.
- Equity Ratio was 0.61 for Q3 2025 at Korro Bio, down from 0.64 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.79 in Q2 2024 and bottomed at 3.31 in Q3 2023.
- Average Equity Ratio over 5 years is 0.11, with a median of 0.68 recorded in 2022.
- The sharpest move saw Equity Ratio crashed 648.64% in 2023, then skyrocketed 165.63% in 2024.
- Year by year, Equity Ratio stood at 0.23 in 2021, then crashed by 489.76% to 1.34 in 2022, then soared by 157.08% to 0.77 in 2023, then decreased by 7.5% to 0.71 in 2024, then decreased by 13.54% to 0.61 in 2025.
- Business Quant data shows Equity Ratio for KRRO at 0.61 in Q3 2025, 0.64 in Q2 2025, and 0.69 in Q1 2025.